Skip to main content
SpringerLink
Log in

Alemtuzumab

Guillain-Barré syndrome (first report) in an elderly patient: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Abbi KK, Rizvi SM, Sivik J, Thyagarajan S, Loughran T, Drabick JJ.Guillain-Barre syndrome after use of alemtuzumab (Campath) in a patient with T-cell prolymphocytic leukemia: a case report and review of the literature. Leukemia Research 34: e154-6, No. 7, Jul 2010 - USA

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alemtuzumab. React. Wkly. 1312, 8 (2010). https://doi.org/10.2165/00128415-201013120-00026

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013120-00026

Keywords

Search

Navigation